Targretin is a cancer medicine used for the treatment of the visible signs on the skin of cutaneous T\-cell lymphoma (CTCL). CTCL is a rare type of lymphoma (cancer of the lymph tissue) where some white blood cells (T\-cells) grow in the skin. Targretin is used in patients who have an advanced disease and have had at least one other treatment.
Therapeutic Indication
Targretin capsules are indicated for the treatment of skin manifestations of advanced stage cutaneous T\-cell lymphoma (CTCL) patients refractory to at least one systemic treatment.
Therapeutic Area (MeSH)
ATC Code
L01XF03
ATC Item
N/A
Pharmacotherapeutic Group
Antineoplastic agents
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| bexarotene | N/A | bexarotene |
EMA Name
Targretin
Medicine Name
Targretin
Aliases
N/ANo risk management plan link.
